New data on ocrelizumab and satralizumab-mwge will be presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) from October 13 – 15, 2021. These data include 38...
Read MoreComing soon…
Read MoreComing soon…
Read MoreComing soon…
Read MoreData from the INFINITY clinical trial of ADVM-022 in patients with diabetic macular edema (DME) during the American Society of Retina Specialists (ASRS) 39th Annual Scientific Meeting and will be presented an encore presentation...
Read MorePositive phase 1 and 2 findings support an ongoing efficacy assessment of the Ref-1 inhibitor for diabetic retinopathy and diabetic macular edema. Investigative oral drug APX3330 has been associated with generally favorable...
Read MoreFindings from a Phase 1/2a clinical trial of its Multi-Characteristic Opsin (MCO) gene therapy for people blinded by retinitis pigmentosa (RP) were highlighted in two presentations during the 2021 Annual Meeting of the American...
Read MoreInitial data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular edema (CI-DME) using in-office suprachoroidal delivery was...
Read MoreInterim safety and clinical activity data from the Phase 1/2 clinical trial of intravitreal 4D-125 in patients with advanced X-linked retinitis pigmentosa (XLRP) was presented in a late-breaking presentation at the American...
Read MorePhase 1/2a clinical trial of its Multi-Characteristic Opsin (MCO) gene therapy for people blinded by retinitis pigmentosa (RP) will be highlighted in two presentations during the 2021 Annual Meeting of the American Society of...
Read MoreThe American Society of Retina Specialists (ASRS) will host its 39th Annual Scientific Meeting from October 8-12, 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas. According to ASRS, its...
Read MoreThe American Society of Retina Specialists (ASRS) will host its 39th Annual Scientific Meeting from October 8-12, 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas. ASRS 2021 serves to...
Read MoreLynne Peterson is the Senior Writer for Trends-in-Medicine.Here is the medical news to watch for Oct. 4-10, 2021.Drug development: The Drug Information Association (DIA) is sponsoring a virtual Biosimilars Conference Oct. 5-6 to...
Read MoreInebilizumab demonstrated favorable long-term safety and efficacy outcomes for patients with neuromyelitis optica spectrum disorder (NMOSD). The 5.5-year follow up results of the open-label extension (OLE) period of the...
Read MoreFindings suggest possible link to onset of diabetes among Covid-19 patients When a person is infected by SARS CoV-2—the pathogen that causes Covid-19 disease—the effects on body organs is pervasive, including...
Read MoreAdagrasib plus cetuximab attacks mutated disease Patients diagnosed with advanced colorectal cancer appear to gain control of their disease if they are treated with a combination of the investigative agent adagrasib and...
Read More
Lynne Peterson is the Senior Writer for Trends-in-MedicineHere is the medical news to watch for Sept. 13-19, 2021.Cardiology—The hybrid Heart Failure Society of America (HFSA) meeting will wind up on Sept....
Read MoreTezepelumab demonstrated significant reduction in annualized exacerbation rate An exploratory analysis of data from the NAVIGATOR phase III trial shows the novel biologic tezepelumab to have significant efficacy in patients with...
Read MoreMeta-analysis showed 11% death reduction in tocilizumab RCTs Among patients hospitalized with Covid-19, treatment with tocilizumab was associated with reduced mortality in a systematic review and meta-analysis. Researchers...
Read More
